Discover & Learn

Discover our tailor-made radiopharmacy solutions, and connect with our experts at booth #2023.

IBA specialists are available to discuss cyclotron and radiochemistry technologies, as well as integrated solutions.

This is an opportunity to exchange on ongoing projects, technical challenges and future development plans in radioisotope production.

The Future of Astatine is here

At SNMMI 2026, discover the latest IBA Astatine-211 dedicated technologies —where precision, reliability, and performance come together for alpha-based targeted cancer therapies.

Be among the first to discover it and get the experts perspective.
Seats are limited → book your seat now
 

• Sunday, May 31 – 3.30 PM
• IBA booth #2023

At Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, discover our end‑to‑end radiopharmacy solutions, from cyclotrons to radiochemistry, designed for reliable production.

Let’s exchange on your projects and challenges, and what comes next.

IBA is your trusted partner in radiochemistry, answering all your needs from routine high volume tracer production to research needs. Our product range is fully automated and offers flexible and customizable options to support research activities. Our chemistry solutions are designed to streamline radiopharmaceutical workflows, enhancing efficiency and throughput while ensuring consistent production of high-quality tracers.

Together, NEPTIS^® and CASSY^® form a complete, flexible, and reliable chemistry portfolio, supporting both routine radiopharmaceutical production and innovation in radiochemistry.

Ekaterina (Kate) Dadachova, PhD, joined University of Saskatchewan in Canada late in 2016 as a Fedoruk Center for Nuclear Innovation Chair in Radiopharmacy, and a Professor of Pharmacy.
 

Before joining University of Saskatchewan, she held a Professorship in Radiology, Microbiology and Immunology at the Albert Einstein College of Medicine in New York, USA from 2000 to 2016.

Her research interests are radioligand therapy of cancer, infections and autoimmune diseases, as well as interaction of melanized fungi with ionizing radiation and melanin-based radioprotectors.
 

She published more than 210 papers, 13 book chapters, and has 8 US patents. She received several awards such as Philips Young Investigator Award by RSNA, Young Professionals Award from the SNM, Mary Kay Ash Research Award, Top 10 researchers at the Albert Einstein College of Medicine in 2013, 2017 Burroughs Welcome Award, 2020 University of Saskatchewan Distinguished Researcher Award and 2024 Saskatchewan Health Research Foundation (SHRF) Years of Service Award. She is in the top 2% of cited scientists worldwide according to Stanford University 2024 database.
 

Prof Dr Ekaterina Dadachova, PhD

• Professor, College of Pharmacy and Nutrition
  & Editor in Chief, Cancer Biotherapy and Radiopharmaceuticals
• Sylvia Fedoruk Center for Nuclear Innovation Chair in Radiopharmacy University of Saskatchewan, Canada

Discover our end‑to‑end radiopharmacy solutions, designed for reliable production.

Let’s exchange on your projects and challenges, and what comes next.